MicroRNA signature in patients with eosinophilic esophagitis, reversibility with glucocorticoids, and assessment as disease biomarkers.
about
Role of Endoscopy in Diagnosis and Management of Pediatric Eosinophilic EsophagitisAllergic mechanisms of Eosinophilic oesophagitisRecent advances in understanding/managing eosinophilic esophagitis in adultsThe pathophysiology of eosinophilic esophagitisA Gene Expression Panel is Accurate for Diagnosis and Monitoring Treatment of Eosinophilic Esophagitis in Adults.Genetic and epigenetic underpinnings of eosinophilic esophagitisSpecific MicroRNA Pattern in Colon Tissue of Young Children with Eosinophilic Colitis.Management of refractory eosinophilic esophagitis.Computational prediction of disease microRNAs in domestic animalsNon- and semi-invasive methods of monitoring eosinophilic esophagitis.Increased prevalence of eosinophilic gastrointestinal disorders in pediatric PTEN hamartoma tumor syndromesAnalysis and expansion of the eosinophilic esophagitis transcriptome by RNA sequencingMicroRNA profiling in mucosal biopsies of eosinophilic esophagitis patients pre and post treatment with steroids and relationship with mRNA targetsPediatric eosinophilic esophagitis is associated with changes in esophageal microRNAs.Decreased expression of microRNA-21 correlates with the imbalance of Th17 and Treg cells in patients with rheumatoid arthritis.Targeted ablation of miR-21 decreases murine eosinophil progenitor cell growth.miRNAs can be generally associated with human pathologies as exemplified for miR-144.Systems biology of asthma and allergic diseases: a multiscale approachPredictors of response to steroid therapy for eosinophilic esophagitis and treatment of steroid-refractory patientsChanges of micro-RNAs in asymptomatic subjects sensitized to Japanese cedar pollen after prophylactic sublingual immunotherapy.Molecular, genetic, and cellular bases for treating eosinophilic esophagitis.MiR-3162-3p Is a Novel MicroRNA That Exacerbates Asthma by Regulating β-Catenin.Utility of a Noninvasive Serum Biomarker Panel for Diagnosis and Monitoring of Eosinophilic Esophagitis: A Prospective Study.Confounding factors affect the pathophysiology of eosinophilic esophagitisATG7 Gene Expression as a Novel Tissue Biomarker in Eosinophilic EsophagitisMiR-223 deficiency increases eosinophil progenitor proliferationThe Impact of Hemolysis on Cell-Free microRNA Biomarkers.The Immunologic Mechanisms of Eosinophilic Esophagitis.Differential microRNA epression in asthma and the role of miR-1248 in regulation of IL-5.Mechanisms of Disease of Eosinophilic Esophagitis.Diagnostic, functional, and therapeutic roles of microRNA in allergic diseases.miR-675-5p enhances tumorigenesis and metastasis of esophageal squamous cell carcinoma by targeting REPS2.MicroRNAs act complementarily to regulate disease-related mRNA modules in human diseases.Possible Noninvasive Biomarker of Eosinophilic Esophagitis: Clinical and Experimental Evidence.Correlation of increased PARP14 and CCL26 expression in biopsies from children with eosinophilic esophagitis.Emerging drugs for eosinophilic esophagitis.Cellular and molecular immunological mechanisms in eosinophilic esophagitis: an updated overview of their clinical implications.MicroRNA regulation of allergic inflammation and asthma.MicroRNAs in Allergic Disease.microRNA and Allergy.
P2860
Q26776253-D8E711ED-2553-40FB-BC59-4082D8B2D1FFQ26778315-5504F2C9-2448-4CD0-821D-3DD682E27267Q26784606-AE66BFE7-7FA3-4B10-9876-CD11F711D6A2Q27011378-6E89D961-9724-4B0C-953F-7F308876D9B9Q30844945-C0364425-4993-499A-9BF4-8071760F771DQ33606257-CB10ABEB-216F-4672-9764-2F65F3001E26Q33755299-C8505297-FC95-46A9-B7A6-A2CB102CCF04Q33844314-508AA444-B017-4E57-B779-F4B75F55CD45Q33881021-A99219F0-A4C1-4C89-AC41-240D02254AADQ34026678-44FBA14A-C842-4D2C-A0F7-D3F10E0A491AQ34030947-FE1205EB-4FFD-412D-961F-CBE58A67AF9BQ34143183-AEC94DEE-DDDC-43DD-9BB7-C982D3C1348FQ34345019-8C65FDCE-396A-4216-B3CE-1F2022B6AC08Q34356060-6C72863D-9B3F-4E71-8658-4C0ACE579BDBQ34473650-44FB519E-536F-478B-8341-878875BBF227Q34637817-3F35B2FF-1BEF-4EF0-AA9A-4490EC948939Q34720619-E00D0001-88AF-466F-8710-4327A34F40FAQ34892932-0E082EC4-FD2A-425B-BCB2-CA7ADD19C47EQ35032854-2214CA4A-B0FF-48B5-9839-2412FE59E21BQ35306850-0F6A3913-54B5-4C7E-9EF3-9E472203282BQ35537424-F59D270D-E156-4832-9B21-A1AE733EF0E9Q35951046-9B7D63B1-3A9D-48F0-96EF-B02DFEA63664Q36082838-E1EBAA13-0EF1-4274-B1CD-0D004EFF5F3AQ36214525-4A9A8F77-9EB2-4765-83A4-42C8072E579CQ36496752-C27A52CA-307E-4A65-805B-F34F942FF9E2Q36586129-BAEB80B0-C7E1-4B29-9E24-1AB8CFF21D1BQ36872732-C3D993C1-B265-4F8E-AEA6-2F7E614FFF27Q37019844-2C5AA010-5EF7-41DB-BFB5-3E0AE4017C2BQ37021673-645D080A-474C-438A-A977-0B1EFD85FB5BQ37031313-059D665F-2A7C-48DD-A6C0-0DE7024A640EQ37080521-0CB7BEF5-31F4-4178-ADB8-C079B13E15CCQ37327593-B7F92598-6E97-4920-8BCA-72D9E6AAABBEQ37365343-D3126818-F347-49ED-AAF5-6E8303C255E2Q37449004-B3FBFE3A-6F63-4A5A-B958-5CB25A3879AFQ37649772-9D74698A-B0C9-43F1-A69E-0D128F5870EBQ38128368-37E18E2D-AF30-4E41-9CE5-D764DD4BAE68Q38205271-52D747D8-37DC-4135-BB93-6C2A8E86EC02Q38562722-BCFAC7E3-2C15-43DA-A663-72B4DB62F0BBQ38825287-E7329366-F26B-41AE-B661-D8175FEA9AD9Q38932407-988D810A-3A8F-4DBC-8379-F9E828C178AE
P2860
MicroRNA signature in patients with eosinophilic esophagitis, reversibility with glucocorticoids, and assessment as disease biomarkers.
description
2012 nî lūn-bûn
@nan
2012 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մարտին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
MicroRNA signature in patients ...... essment as disease biomarkers.
@ast
MicroRNA signature in patients ...... essment as disease biomarkers.
@en
MicroRNA signature in patients ...... essment as disease biomarkers.
@nl
type
label
MicroRNA signature in patients ...... essment as disease biomarkers.
@ast
MicroRNA signature in patients ...... essment as disease biomarkers.
@en
MicroRNA signature in patients ...... essment as disease biomarkers.
@nl
prefLabel
MicroRNA signature in patients ...... essment as disease biomarkers.
@ast
MicroRNA signature in patients ...... essment as disease biomarkers.
@en
MicroRNA signature in patients ...... essment as disease biomarkers.
@nl
P2093
P2860
P50
P921
P1476
MicroRNA signature in patients ...... essment as disease biomarkers.
@en
P2093
Andrew J Plassard
James P Franciosi
John A Besse
Joseph D Sherrill
Marc E Rothenberg
Michael Eby
Philip E Putnam
P2860
P304
1064-75.e9
P356
10.1016/J.JACI.2012.01.060
P407
P577
2012-03-03T00:00:00Z